ARC Group Celebrates New Chapter with Opening of Hong Kong Office

ARC Group Celebrates New Chapter with Opening of Hong Kong Office

ARC Group marked another significant milestone last week with the official opening of its new Hong Kong office, located in the heart of Central at 162 Queen’s Road Central. Situated on the 5th floor of the On Building, this new office underscores ARC Group’s continued growth and its strategic commitment to strengthening its presence in Asia.

The opening event, held on June 27, 2025, brought together a distinguished group of clients, partners, and industry leaders to celebrate this exciting new chapter. Guests from across Asia and Europe gathered to connect, exchange insights, and honor ARC Group’s ongoing journey of expansion and innovation.

The evening offered guests the chance to connect, share insights on regional opportunities and global market trends. Light refreshments were served throughout the event, creating a warm and welcoming environment for meaningful exchanges.

Reflecting on this milestone, Valentin Ischer, Managing Director at ARC Group, shared:

“This new office represents a pivotal step in our continued growth and our commitment to supporting clients across Asia and beyond. Hong Kong has long been a critical hub for international business, and our new space enables us to be even closer to our clients and partners. We look forward to deepening relationships and driving.”

 

ARC Group Hong Kong office opening

ARC Group Hong Kong office opening

ARC Group Hong Kong office opening

ARC Group Hong Kong office opening

ARC Group Hong Kong office opening

ARC Group Hong Kong office opening

Continue reading

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (“BGLC” or the “Company”), an emerging provider of precision oncology diagnostics with expanding operations across Southeast Asia, today announced it has entered into a $500,000,000 Equity Purchase Agreement (the “Facility”) with ARC Group International Ltd. (“ARC”), a global investment bank and the parent […]
ARC Group Recognized Among Asias Top M&A Advisory Firms for 2025
ARC Group Recognized Among Asia’s Top Consulting Firms for 2025

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission